493
Views
31
CrossRef citations to date
0
Altmetric
Letters to the Editor

A phase I study of elesclomol sodium in patients with acute myeloid leukemia

Pages 2437-2440 | Received 17 Sep 2015, Accepted 28 Dec 2015, Published online: 05 Feb 2016
 

Acknowledgements

We thank Jill Flewelling for administrative assistance. ADS holds the Baker chair in leukemia and related disorders.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2016.1138293.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.